NCT02931214View on ClinicalTrials.gov

Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

November 30, 2018

Conditions
Healthy
Interventions
DRUG

GMI-1359

DRUG

Placebo

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

GlycoMimetics Incorporated

INDUSTRY